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Abstract
The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) score is an invasive coronary
angiography (ICA)-based score for quantifying the complexity of coronary artery disease (CAD). Although the SYNTAX score was
originally developed based on ICA, recent publications have reported that coronary computed tomography angiography (CCTA) is a
feasible modality for the estimation of the SYNTAX score.
The aim of our study was to investigate the prognostic value of the SYNTAX score, based on CCTA for the prediction of major
adverse cardiac and cerebrovascular events (MACCEs) in patients with complex CAD.
The current study was approved by the institutional review board of our institution, and informed consent was waived for this
retrospective cohort study. We included 251 patients (173 men, mean age 66.0±9.29 years) who had complex CAD [3-vessel
disease or left main (LM) disease] on CCTA. SYNTAX score was obtained on the basis of CCTA. Follow-up clinical outcome data
regarding composite MACCEs were also obtained. Cox proportional hazards models were developed to predict the risk of MACCEs
based on clinical variables, treatment, and computed tomography (CT)-SYNTAX scores.
During the median follow-up period of 1517 days, there were 48 MACCEs. Univariate Cox hazards models demonstrated
that MACCEs were associated with advanced age, low body mass index (BMI), and dyslipidemia (P< .2). In patients with LM
disease, MACCEs were associated with a higher SYNTAX score. In patients with CT-SYNTAX score ≥23, patients who
underwent coronary artery bypass graft surgery (CABG) and percutaneous coronary intervention had signiﬁcantly lower
hazard ratios than patients who were treated with medication alone. In multivariate Cox hazards model, advanced age, low
BMI, and higher SYNTAX score showed an increased hazard ratio for MACCE, while treatment with CABG showed a lower
hazard ratio (P< .2).
On the basis of our results, CT-SYNTAX score can be a useful method for noninvasively predicting MACCEs in patients with
complex CAD, especially in patients with LM disease.
Abbreviations: BMI = body mass index, CABG = coronary artery bypass graft surgery, CAD = coronary artery disease, CCTA =
coronary computed tomography angiography, ICA = invasive coronary angiography, LM = left main, MACCE = major adverse
cardiac and cerebrovascular event, MI = myocardial infarction, MPR = multiplanar reformat, PCI = percutaneous coronary
intervention, SYNTAX = SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery, UA = unstable
angina.
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Figure 1. Flow chart of the study population. CCTA = coronary computed
tomography angiography; CABG= coronary artery bypass graft surgery; PCI=
percutaneous coronary intervention.
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The complexity of coronary artery disease (CAD) is one of the
main factors inﬂuencing the selection of treatment modality in
patients with CAD, in addition to the extent of myocardial
ischemia, patient and clinician preference, and other patient
comorbidities.[1] Coronary artery bypass graft surgery (CABG)
has been the standard of care for the revascularization of patients
with complex CAD such as multivessel and left main (LM)
coronary disease.[1] However, with the advancement of operator
ability and device technologies for percutaneous coronary
intervention (PCI), the use of PCI has expanded to the treatment
of patients with increasingly complex CAD. The optimum
method for the revascularization of these patients has been a
matter of debate.
The SYNergy between PCI with TAXus and cardiac surgery
(SYNTAX) score has been developed to calculate complexity of
CAD based on invasive coronary angiography (ICA).[2] The ICA-
SYNTAX score can predict major adverse cardiac and
cerebrovascular events (MACCEs) in populations with complex
CAD (LM disease or 3-vessel disease),[3] and guide the optimal
revascularization strategy. Among patients with complex CAD,
CABG remains as the standard of care for patients with high
(≥33) or intermediate (23–32) SYNTAX scores, whereas PCI is
an acceptable alternative in patients with less complex disease
(SYNTAX score 22).[4] Recent studies have reported the
feasibility of coronary computed tomography angiography
(CCTA) for the SYNTAX score.[5–9] A previous study demon-
strated that the CT-SYNTAX score may have prognostic value
for predicting major adverse cardiac events in patients with
varying severities of CAD.[8] Nevertheless, the use of the CT-
SYNTAX score in patients with complex CAD has not yet been
well-established. Considering the high diagnostic accuracy of CT
for CAD and the excellent correlation between the CT-SYNTAX
score and ICA-SYNTAX score, we hypothesized that the CT-
SYNTAX score may have prognostic value in patients with
complex CAD.
The aim of our study was to investigate the prognostic value of
the CT-SYNTAX score for the prediction ofMACCEs in patients
with complex CAD.2. Methods
2.1. Patients
This study was approved by the institutional review board of our
institution, and informed consent was waived. For this retro-
spective cohort study, we included 302 patients from a CCTA
database of our institution, who met both of the following 2
criteria: LM or 3-vessel disease documented on dual-source
CCTA from February 2010 to July 2011 and no previous PCI or
CABG. Fifty-one patients who were lost to follow-up (i.e., a
follow-up period shorter than 4 years) were excluded from the
study. Finally, a total of 251 patients consisted of our study
population (Fig. 1). Of these patients, 92 and 54 were included in
previous studies by Suh et al.[8,9] One study evaluated the long-
term prognostic value of the CT-SYNTAX score in a population
who underwent both CCTA and ICA, and compared the
prognostic value of the CT-SYNTAX score and ICA-SYNTAX
score.[8] Another study investigated the diagnostic accuracy of
CCTA and the CT-SYNTAX score for selection of CABG
candidates.[9] Our study focused on the prognostic value of the
CT-SYNTAX score in patients with complex CAD as docu-
mented on CCTA. Demographic data and information on2cardiovascular risk factors were collected from the electronic
medical records.
2.2. Image acquisition
Computed tomographic (CT) scans were performed using a dual-
source CT scanner (SOMATOM Deﬁnition Flash; Siemens
Health Care, Forchheim, Germany), as described in detail
previously.[8] Image reconstructions were conducted as previous-
ly described, using ﬁltered back projection with a medium kernel
(b36f), and the slice thickness of 0.75mm with 0.5mm
increments.[8]
2.3. Image analysis
The CCTA images were independently analyzed by 2 reviewers
who were blinded to the clinical history, and ﬁnal diagnosis was
made by consensus reading in case of interreader discrepancies.
Presence of signiﬁcant CAD (>50% stenosis in diameter) was
analyzed using a 16-segment model from the American Heart
Association classiﬁcation.[10]2.4. Calculation of the CT-SYNTAX Score
CT-SYNTAX score was obtained using the SYNTAX score
calculator version 2.11 (www.syntaxscore.com),[2] as previously
described.[5,11] Two reviewers independently calculated the
SYNTAX score and the ﬁnal score was made by a consensus.
2.5. Follow-up data
From the electronic medical records, follow-up data were
reviewed and collected. The primary end point was the
occurrence of MACCEs, including cardiac death, nonfatal
myocardial infarction (MI), unstable angina (UA) requiring
hospitalization, revascularization either by PCI or CABG after 90
days from index CCTA, or stroke.
2.6. Statistical analysis
Categorical variables were expressed as numbers with percen-
tages, and continuous variables are expressed as means with
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using the Chi-square or Fisher exact tests for categorical
variables, and using the Student t test or Mann–Whitney U test
for continuous variables. We set 2 subgroups according to the
extent of anatomical CAD: patients with LM disease (with or
without additional vessel involvement), and those with 3-vessel
disease in the absence of LM disease. Moreover, patients were
divided according to the CT-SYNTAX score into 3 categories:
score<22, 23 to 32, or ≥33. Cumulative event rates were
demonstrated using Kaplan–Meier survival curve for the CT-
SYNTAX score groups and compared using the log-rank test.
Cox regression analyses were used to identify predictors of
MACCEs. Hazard ratios were assessed as an estimation of risk
with 95% conﬁdence intervals (95% CIs). The predictive ability
of Cox regression was assessed using Harrell c statistics.[12] A P
value of less than .05 was considered statistically signiﬁcant,
although a P value of less than .2 was the cutoff for statistical
signiﬁcance in the Cox regression analyses. All analyses were
performed with R (version 3.2.4.; R Foundation for Statistical
Computing, Vienna, Austria).3. Results
3.1. Patient characteristics
The study population consisted of 251 patients (173 men, mean
age 66.0±9.29 years). The clinical characteristics are demon-
strated in Table 1. One hundred eighty-seven patients (74.5%)
had 3-vessel disease without LM disease, and 37 patients
(14.7%) had LM disease without 3-vessel disease. Twenty-
seven patients (10.8%) showed LM disease with 3-vessel
disease.3.2. SYNTAX score based on CCTA
The CT-SYNTAX score had a median of 17 (25th to 75th
percentile, 12.3–23). When patients were divided into 3 subsets
based on SYNTAX score, the number of patients in each groupTable 1
Baseline characteristics of the study group according to the SYNTA
SYNTAX group 1 (n=182) SYNTAX
Male 120
Age 65.4±9.41 6
BMI 24.2±3.43 2
Diabetes 57
Hypertension 111
Dyslipidemia 29
Current smoker 29
Chest pain
Typical 27
Atypical 46
Nonanginal 41
Asymptomatic 68
LVEF 65.4±10.9 (n=145) 60.4
Pretest probability
Very low 2
Low 63
Intermediate 88
High 20
Nonapplicable 9
Data are numbers of patients with percentages in parentheses.
BMI=body mass index, CCTA= coronary computed tomography angiography, LVEF= left ventricular eje
Bold values indicate statistical signiﬁcance.
3was as follows: SYNTAX score group 1 (22, n=182), group 2
(23–32, n=50), and group 3 (≥33, n=19).
3.3. Follow-up data and clinical and CT variables
associated with MACCEs
During the median follow-up period of 1517 days (25th to 75th
percentile, 1312–1674 days), there were a total of 48 MACCEs
(event rate 19.1%). The 48 composite MACCEs included 23
cardiac deaths, 1 nonfatal MI, 2 episodes of UA requiring
hospitalization, 12 revascularizations after 90 days of index test,
3 cases of nonfatal MI and late revascularization, 3 cases of UA
requiring hospitalization and late revascularization, and 4
strokes. Early revascularization (less than 90 days after index
CT) was performed in 149 patients (106 PCI and 43 CABG).
Figure 2 depicts the Kaplan–Meier estimates of the cumulative
probability ofMACCEs as stratiﬁed by the SYNTAX score based
on CCTA. Kaplan–Meier survival curves showed that cumulative
events did not signiﬁcantly increase with CT-SYNTAX score in
the overall study group and in patients without LM disease (log-
rank test, P> .05). However, the cumulative events showed a
signiﬁcant increase with increasing CT-SYNTAX scores in
patients with LM disease (P= .037). Figure 3 demonstrates the
Kaplan–Meier estimates of the cumulative probability of
MACCEs according to the treatment methods. In the overall
study group, no signiﬁcant difference was observed in the
cumulative events between the treatment methods. In patients
with a low SYNTAX score (0–22), the cumulative event rate was
not different according to the treatment, whereas patients with an
intermediate or high SYNTAX score (≥23) showed a signiﬁcant
difference between groups (P= .028).
In univariate Cox regression analysis, advanced age, low BMI,
and dyslipidemia were predictors of MACCEs among the clinical
variables (P< .2, Table 2). Sex, hypertension, diabetes, smoking,
and Framingham risk score were not associated with increasing
hazard ratios for MACCEs. Patients with a high SYNTAX score
(≥33) showed an increased hazard ratio (2.054, 95% CI
0.857–4.93) for MACCEs compared with patients with a lowX score category on CCTA.
group 2 (n=50) SYNTAX group 3 (n=19) P
38 15 .197
7.0±8.97 68.2±8.79 .310
4.3±2.97 23.9±2.21 .917
11 6 .375
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Figure 2. Kaplan–Meier curves for the prediction of MACCEs according to the CT-based SYNTAX score (A) in the entire population, (B) patients with LM disease,
and (C) patients with 3-vessel disease without LM involvement. All patients (n=251, P= .222), patients with LM disease (n=64, P= .037), (c) patients with 3-vessel
disease without LM involvement (n=187, P= .899). CT = computed tomography; LM = left main coronary artery; MACCE = major adverse cardiac and
cerebrovascular event.
Suh et al. Medicine (2017) 96:37 MedicineSYNTAX score (0–22) (P= .107). In patients with LM disease,
MACCEs tended to increase with higher SYNTAX scores
(P< .2). With regard to treatment method, patients who
underwent CABG showed decreased hazard ratios for MACCEs
compared with patients who received medical treatment (0.352,
95% CI 0.123–1.01; P= .0528). In the subgroup analysis ofFigure 3. Kaplan–Meier curves for the prediction of MACCEs according to the tre
n=182, P= .708), SYNTAX score group 2 (23–32; n=50, P= .118), SYNTAX scor
P= .028), CABG = coronary artery bypass graft surgery; MACCE =major adverse
4patients with intermediate to high SYNTAX scores (≥23),
patients with PCI and CABG showed decreased hazard ratios for
MACCEs compared with patients who received medical
treatment (hazard ratio 0.489, 95% CI 0.167–1.431, P= .192
for PCI; hazard ratio 0.158, 95%CI 0.0345–0.721, P= .0172 for
CABG). In multivariate analysis, patients with advanced age, lowatment methods, all patients (n=251, P= .113), SYNTAX score group 1 (0–22;
e group 3 (≥33; n=19, P= .0989), SYNTAX score group 2 and 3 (≥33, n=69,
cardiac and cerebrovascular event; PCI = percutaneous coronary intervention.
Table 2
Univariate Cox regression analysis for the prediction of MACCEs.
Variables HR 95% CI P
Clinical variables
Sex
Male 1 Reference
Female 0.7154 0.3722–1.375 .315
Age 1.0561 1.0215–1.0919 .0014
BMI 0.9121 0.8566–0.9712 .0041
Hypertension
No 1 Reference
Yes 1.188 0.652–2.166 .573
Diabetes
No 1 Reference
Yes 0.8776 0.4643–1.659 .6876
Dyslipidemia
No 1
Yes 0.4961 0.1964–1.253 .1381
Smoke .9343
Never smoker 1 Reference
Former smoker 0.9998 0.5191–1.923 .998
Current smoker 1.1460 0.5347–2.455 .727
FRS 1.022 0.9879–1.058 .205
LVEF 1.001 0.9741–1.03 .936
CT-SYNTAX score (continuous) 1.026 0.992–1.061 .136
CT-SYNTAX score (group)
Entire group .2489
Group 1 (SYNTAX score 0–22) 1 Reference
Group 2 (SYNTAX score 23–32) 1.299 0.6526–2.584 .457
Group 3 (SYNTAX score ≥33) 2.054 0.8569–4.925 .107
Patients with LM disease
Group 1 (SYNTAX score 0–22) 1 Reference
Group 2 (SYNTAX score 23–32) 4.946 0.9969–24.54 .0504
Group 3 (SYNTAX score ≥33) 6.769 1.2384–37.00 .0273
Patients without LM disease
Group 1 (SYNTAX score 0–22) 1 Reference
Group 2 (SYNTAX score 23–32) 0.8236 0.3185–2.129 .689
Group 3 (SYNTAX score ≥33) 1.3018 0.3104–5.461 .718
Treatment
Entire group
Medical treatment 1 Reference
PCI 0.6903 0.3800–1.254 .2236
CABG 0.3524 0.1226–1.012 .0528
Group 1 (SYNTAX score 0–22)
Medical treatment 1 Reference
PCI 0.8339 0.4023–1.729 .625
CABG 0.5643 0.1290–2.468 .447
Group 2 and 3 (SYNTAX score ≥23)
Medical treatment 1 Reference
PCI 0.4889 0.1670–1.4311 .1916
CABG 0.1577 0.0345–0.7207 .0172
BMI=body mass index, CABG= coronary artery bypass graft surgery, CI= conﬁdence interval, FRS= Framingham risk score, HR=hazard ratio, LM= left main coronary artery, LVEF= left ventricular ejection
fraction, MACCE=major adverse cardiac and cerebrovascular event, PCI=percutaneous coronary intervention.
Bold values indicate statistical signiﬁcance.
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and treatment with CABG resulted in a lower hazard ratio
(Table 3, P< .2; Harrell C statistic=0.675).4. Discussion
Our study shows that the CT-based SYNTAX score has
prognostic value for predicting MACCEs and for guiding
optimal treatment methods in patients with complex CAD on
CCTA. Patients with a high SYNTAX score (≥33) showed an
increased hazard ratio forMACCEs compared with patients with5a low SYNTAX score (0–22). In particular, MACCEs tended to
increase with higher SYNTAX scores in patients with LM
disease. In patients with a CT-SYNTAX score ≥23, those who
underwent CABG and PCI showed signiﬁcantly lower hazard
ratios than patients who were treated with medication alone. In
the multivariate analysis, clinical factors such as advanced age
and low BMI in addition to higher SYNTAX scores resulted in
higher hazard ratios for MACCES, while treatment with CABG
resulted in lower hazard ratios.
The prognostic value of the SYNTAX score calculated from
ICA has been well-established, indicating that a high SYNTAX
Table 3
Multivariate Cox regression analysis for the prediction of MACCEs.
Variables HR 95% CI P
Clinical variables
Age 1.0388 1.0035–1.0753 .0311
BMI 0.9358 0.8715–1.0048 .0676
Dyslipidemia 0.5786 0.2235–1.4982 .2597
Treatment
Medical treatment 1 (Reference)
PCI 0.9233 0.4959–1.7190 .8013
CABG 0.3279 0.1089–0.9873 .0474
CT-SYNTAX score
Group 1 (SYNTAX score 0–22) 1 (Reference)
Group 2 (SYNTAX score 23–32) 1.6052 0.7900–3.2615 .1907
Group 3 (SYNTAX score ≥33) 2.7442 1.0976–6.8614 .0308
BMI=body mass index, CABG=coronary artery bypass graft surgery, CI= conﬁdence interval, HR=hazard ratio, MACCE=major adverse cardiac and cerebrovascular event, PCI=percutaneous coronary
intervention.
Bold values indicate statistical signiﬁcance.
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revascularization (PCI or CABG).[4,13–19] A recent randomized
clinical trial reported that among patients with complex CAD, the
low (0–22) SYNTAX score group did not have signiﬁcantly
different rates of MACCEs between treatment groups (CABG vs
PCI). In contrast, patients with intermediate (23–32) or high
SYNTAX scores (≥33) had signiﬁcantly increasedMACCEs with
PCI than with CABG.[4] Outcomes based on the overall results of
this trial at 5 years suggest that CABG should remain the
standard of care for patients with high or intermediate SYNTAX
scores, while PCI is an acceptable alternative for patients with
low SYNTAX scores.[4] Consistently, CABG is recommended for
improving survival in patients with signiﬁcant LM disease or 3-
vessel disease as class I recommendation, whereas PCI is
considered as a reasonable alternative to CABG in case of
signiﬁcant LM disease with low SYNTAX score (22) as class IIa
recommendation, and low-intermediate SYNTAX score (<33) as
class IIb recommendation.[1] Similarly, in our study, hazard ratios
for the occurrence of MACCEs were different according to
treatment methods in patients with intermediate or high CT-
SYNTAX scores (≥23), but not in patients with low CT-
SYNTAX scores (0–22). This result may suggest that CCTA can
be a useful modality to calculate the complexity of CAD and
stratify patients for appropriate treatment planning.
Most previous studies on the SYNTAX score based on CCTA
have focused on the feasibility and reproducibility of CT-based
SYNTAX scoring by using ICA-based SYNTAX score as a
reference standard, and showed both a positive correlation and
moderate-to-good agreement between CT-SYNTAX score and
ICA-SYNTAX score.[5,7,11,20,21] A previous study reported high
diagnostic accuracy (sensitivity 80% and speciﬁcity 83%) of CT-
STYNAX score for detecting patients with high SYNTAX score
(≥33) categories.[7] CCTA offers advantages over ICA in
calculating SYNTAX score in case of assessing the length of
the occluded segment, as well as for evaluating LM ostial lesion,
as LM lesions by ICA is difﬁcult to assess due to vessel overlap
and foreshortening.[7,9,22] CT-SYNTAX score can have various
clinical applications for classifying patients with CAD, predicting
complex PCI, and selecting CABG candidates. [7,9,22–24] As of
now, only 1 study has reported the prognostic value of CT-
SYNTAX score in patients who underwent both CCTA and
ICA.[8] Interestingly, on both CCTA and ICA, high SYNTAX
scores increased hazard ratios compared with low SYNTAX
scores.[8] However, the SYNTAX score was initially designed to6quantify the complexity of LM or 3-vessel disease, and
calculating the SYNTAX score is considered to be more valuable
in complex CAD. As the study population of the previous study
included patients with varying extents of CAD, patients with
complex CAD consisted of only 21.9% of the overall population.
In contrast, all of our study population had complex CAD on
CCTA, and the result of multivariate Cox hazard model
demonstrated that increasing CT-SYNTAX score was an
independent predictor for MACCEs in patients with complex
CAD. Such result may support the hypothesis that the SYNTAX
score based on CCTA has prognostic value in patients with
complex CAD.
In addition to the CT-SYNTAX score and treatment methods,
clinical risk factors such as age and BMI were revealed to be
independent predictors for MACCEs in our study. Advanced age
and obesity are considered as risk factors of CAD. However,
lower BMI was associated with higher MACCEs in our study. In
fact, the impact of BMI on the occurrence of MACCEs is
controversial. Previous studies have reported that overweight or
obesity was related with similar or lower mortality and MACCE
after coronary revascularization.[25] This gives rise to the
“obesity paradox” and can be explained by selection bias in
previous investigations, the effect of increased metabolic reserve
due to obesity, and improved outcomes after revascularization
because of larger vessel size and easier stent placement in patients
with large body size.[26,27]
Our study had some limitations. First, as the current study was
a retrospective study performed at a single institution, the number
of patients was relatively small and selection bias was possible. In
particular, the loss of a substantial number (51 of 302 patients,
16.9%) of patients during follow-up could have been a
considerable limitation. Second, among 48 MACCEs that
occurred in our study population, only 24 cases (50%) had a
hard outcome (23 cardiac deaths and 1 nonfatal MI). Third, CT-
based SYNTAX score may be different from ICA-based
SYNTAX score, which may result in different SYNTAX group
categories between the 2 modalities. However, previous studies
reported a good correlation between CT-based and ICA-based
SYNTAX scores in patients with complex CAD, and a good
agreement for classifying the SYNTAX score categories.[7]
Although the CT-SYNTAX scores may be valuable for
noninvasively stratifying patients based on clinical outcomes
and providing information about the optimal treatment strategy,
the importance of ICA should not be overlooked, considering
[13] Palmerini T, Genereux P, Caixeta A, et al. Prognostic value of the
Suh et al. Medicine (2017) 96:37 www.md-journal.comfurther information by ICA with fractional ﬂow reserve and
intracoronary imaging for corrective diagnosis and appropriate
treatment. Finally, we did not consider other factors that can
affect treatment selection and prognosis, such as myocardial
ischemia and coronary plaque characteristics. We believe that a
future prospective study using a larger population may be able to
address this issue.
In conclusion, the CT-SYNTAX score can be a useful method
for noninvasively predicting MACCEs and for guiding treatment
methods in patients with complex CAD. A higher SYNTAX score
was associated with increasing MACCEs and treatment with
CABG was associated a lower hazard ratio for MACCEs.
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